Medicine and Dentistry
Diseases
100%
Systematic Review
92%
Apoplexy
90%
Surgery
83%
Overall Survival
82%
Mechanical Thrombectomy
81%
Magnetic Resonance Imaging
79%
Neoplasm
77%
Meta-Analysis
74%
Pediatrics
72%
COVID-19
69%
Epileptic Seizure
68%
Quality of Life
64%
Infection
63%
Odds Ratio
63%
Brain Ischemia
63%
Biological Marker
60%
Adverse Event
58%
Aneurysm
56%
Diagnosis
55%
Malignant Neoplasm
55%
Adolescence
54%
Drug Therapy
52%
Cohort Analysis
52%
Retrospective Study
50%
Epidermolysis bullosa
50%
Neck
49%
Comorbidity
48%
Status Epilepticus
46%
Prevalence
46%
Heart Rehabilitation
45%
Breast Cancer
44%
Computer Assisted Tomography
43%
Prostate Cancer
41%
Hazard Ratio
41%
Randomized Controlled Trial
40%
Severe Acute Respiratory Syndrome Coronavirus 2
38%
Internal Fixation
38%
Rectum Cancer
37%
Recurrent Disease
36%
Colorectal Carcinoma
36%
Body Mass Index
36%
Cardiovascular Disease
36%
Surgeon
36%
Modified Rankin Scale
35%
Health Care Cost
33%
Congestive Heart Failure
33%
Propensity Score Matching
33%
Progression Free Survival
33%
Intracranial Aneurysm
32%
Systemic Therapy
32%
Atrial Fibrillation
32%
Prematurity
32%
Microsurgery
30%
Injury
29%
Melanoma
29%
Cerebral Hemorrhage
29%
Cardiovascular System
29%
Cross Sectional Study
28%
Clinical Trial
28%
Retrospective Cohort Study
27%
Partial Seizure
27%
Aortic Valve Stenosis
27%
Observational Study
26%
Percutaneous Aortic Valve Replacement
26%
Epilepsy Surgery
26%
Positron Emission Tomography-Computed Tomography
26%
Transitional Cell Carcinoma
25%
Lung
25%
Cardiology
25%
Secondary Prevention
25%
Bleeding
25%
Middle Cerebral Artery
25%
Mortality Rate
25%
Exercise
24%
Ovarian Cancer
24%
Outpatient
24%
Chemoradiotherapy
24%
Acute Kidney Injury
24%
Survival Rate
24%
Open Reduction (Procedure)
23%
Pulmonary Hypertension
23%
Physical Activity
22%
Geriatrics
22%
Arm
22%
Diagnostic Performance
22%
Middle Cerebral Artery Occlusion
21%
Embolization
21%
Transplantation
21%
Chemotherapy
21%
Decision Making
21%
Pelvis
21%
Neoadjuvant Chemotherapy
20%
Clinician
20%
Radiation Therapy
20%
Percutaneous Thrombectomy
20%
Cancer Surgery
20%
Digital Health
20%
Neoadjuvant Therapy
19%
Olaparib
19%
Pharmacology, Toxicology and Pharmaceutical Science
Disease
95%
Chemotherapy
58%
Biological Marker
57%
Overall Survival
56%
Adverse Event
52%
Cohort Study
43%
Neoplasm
42%
Malignant Neoplasm
41%
Epidermolysis bullosa
40%
Breast Cancer
36%
Infection
36%
Cerebrovascular Accident
34%
SARS Coronavirus
34%
Recurrent Disease
33%
Prostate Cancer
33%
Congestive Heart Failure
33%
Clinical Trial
32%
Epileptic State
32%
Observational Study
31%
Inflammation
29%
Comorbidity
25%
Randomized Controlled Trial
25%
Progression Free Survival
24%
Pulmonary Hypertension
24%
Cardiovascular Disease
24%
Placebo
23%
Polyethylene Terephthalate
22%
Syndrome
22%
Nonalcoholic Fatty Liver
20%
Hospital Mortality
20%
Olaparib
19%
Squamous Cell Carcinoma
19%
Atrial Fibrillation
19%
Retrospective Study
19%
Prevalence
19%
Heart Infarction
18%
Liver Disease
18%
Focal Epilepsy
17%
Aortic Valve Stenosis
17%
Infarction
17%
Coronary Artery Disease
17%
Survival Rate
17%
Cancer Staging
17%
Injury
16%
Non Insulin Dependent Diabetes Mellitus
16%
Acute Myeloid Leukemia
16%
Non Small Cell Lung Cancer
16%
Tolerability
16%
Childhood Obesity
15%
Pharmacotherapy
15%
Melanoma
15%
Fluorodeoxyglucose F 18
15%
Ovary Cancer
14%
Global Disease Burden
14%
Chronic Kidney Failure
14%
Empagliflozin
14%
Lutetium 177
14%
Intervertebral Disk Degeneration
14%
Cyclooxygenase 2
14%
Pancreas Cancer
14%
Aneurysm
14%
Circulating Tumor DNA
14%
Brain Ischemia
14%
Disease Course
14%
Mortality Rate
13%
Side Effect
13%
Bleeding
13%
Brain Hemorrhage
13%
Remdesivir
13%
Fatty Liver
13%
Pharmacokinetics
12%
Pembrolizumab
12%
Rankin Scale
12%
Castration Resistant Prostate Cancer
12%
Natriuretic Factor
12%
Coronavirinae
12%
Liver Fibrosis
12%
Disease Free Survival
11%
Remission
11%
Acute Kidney Failure
11%
Sodium Glucose Cotransporter 2 Inhibitor
11%
Prospective Cohort Study
11%
Anemia
11%
Acute Heart Infarction
11%
Inflammatory Bowel Disease
10%
Multiple Sclerosis
10%
Gallium 68
10%
Bevacizumab
10%
Irisin
10%
Frailty
10%
Epidermolysis Bullosa Dystrophica
10%
Sudden Cardiac Death
10%
Chemoradiation Therapy
10%
Colorectal Carcinoma
9%
Rectum Cancer
9%
Glycogen Storage Disease
9%
Prostate Specific Membrane Antigen
9%
Bovine Serum Albumin
9%
Ferroptosis
9%
Spinal Cord Injury
9%